AQR Arbitrage’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

AQR Arbitrage’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$212K	Sell	282,120 -8,030	-3%	-$6.28K	﹤0.01%	385
2025 Q4	$206K	Sell	290,150 -105,907	-27%	-$88.4K	﹤0.01%	375
2025 Q3	$297K	Hold	396,057	–	–	0.01%	322
2025 Q2	$339K	Hold	396,057	–	–	0.01%	278
2025 Q1	$297K	Buy	396,057 +1	+0%	+$1	0.01%	271
2024 Q4	$285K	Buy	+396,056	New	+$259K	0.01%	305

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

AQR Arbitrage's OACCW Position: Q1 2026 in Review

AQR Arbitrage reduced its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 2.8% in Q1 2026, selling an estimated $6.28K and leaving 282,120 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

AQR Arbitrage first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $339K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

AQR Arbitrage held 282,120 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $212K as of Q1 2026.
AQR Arbitrage sold 8,030 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $6.28K.
Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of AQR Arbitrage's portfolio in Q1 2026, its #385 holding.
AQR Arbitrage first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
AQR Arbitrage's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $339K in Q2 2025.
26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.